Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives $18.38 Average Price Target from Analysts

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $18.38.

Several equities research analysts have recently issued reports on the company. Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $16.00 to $20.00 in a report on Tuesday, October 1st. Scotiabank raised their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. Truist Financial raised their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their price objective for the company from $17.00 to $20.00 in a research note on Friday, September 13th.

Sabra Health Care REIT Trading Up 1.0 %

Shares of NASDAQ SBRA opened at $19.27 on Friday. Sabra Health Care REIT has a one year low of $12.83 and a one year high of $19.33. The firm has a market capitalization of $4.46 billion, a PE ratio of 96.35, a PEG ratio of 2.69 and a beta of 1.26. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89. The business has a 50-day moving average price of $18.04 and a two-hundred day moving average price of $16.09.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The business had revenue of $176.14 million for the quarter, compared to analyst estimates of $166.54 million. During the same quarter in the previous year, the business posted $0.34 earnings per share. The company’s revenue was up 9.3% compared to the same quarter last year. As a group, analysts predict that Sabra Health Care REIT will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 19th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.23%. The ex-dividend date was Monday, August 19th. Sabra Health Care REIT’s dividend payout ratio is currently 600.00%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in shares of Sabra Health Care REIT by 2.5% during the first quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust’s stock valued at $516,545,000 after purchasing an additional 838,654 shares during the period. Janus Henderson Group PLC boosted its stake in Sabra Health Care REIT by 2.9% in the 1st quarter. Janus Henderson Group PLC now owns 5,199,682 shares of the real estate investment trust’s stock valued at $76,701,000 after buying an additional 145,548 shares in the last quarter. LSV Asset Management boosted its stake in Sabra Health Care REIT by 2.5% in the 2nd quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust’s stock valued at $67,465,000 after buying an additional 104,800 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Sabra Health Care REIT by 3.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust’s stock valued at $52,275,000 after buying an additional 124,825 shares in the last quarter. Finally, APG Asset Management US Inc. boosted its stake in Sabra Health Care REIT by 28.9% in the 2nd quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust’s stock valued at $39,495,000 after buying an additional 575,000 shares in the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.